The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus

Lupus

Volumn 23, Issue 12, 2014, Pages 1327-1331

  Salem, D ^a   Subang, R ^a   Laplante, P ^a,c   Levine, J S ^b   Rauch, J ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

antiphospholipid antibodies; Antiphospholipid syndrome; epitope spread; innate immunity; systemic lupus erythematosus; toll like receptor 4; 2 glycoprotein I

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; EPITOPE; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHOLIPID ANTIBODY; PHOSPHOLIPID BINDING PROTEIN; TOLL LIKE RECEPTOR 4; PROTHROMBIN;

ANTIGEN PRESENTING CELL; ANTIPHOSPHOLIPID SYNDROME; B LYMPHOCYTE; BLOOD CLOTTING; CELL ADHESION; CELL DEATH; CELL SURFACE; CONFERENCE PAPER; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PATHOGENESIS; PROLIFERATIVE GLOMERULONEPHRITIS; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; THROMBOCYTE AGGREGATION; ANIMAL; APOPTOSIS; BLOOD; IMMUNOLOGY; MOUSE; PHYSIOLOGY; THROMBOSIS;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; APOPTOSIS; BETA 2-GLYCOPROTEIN I; IMMUNITY, INNATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; PROTHROMBIN; THROMBOSIS;

EID: 84908673354     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314548248     Document Type: Conference Paper

References (13)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
2. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002 ; 346: 752-763
3. Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: Understanding the antibodies. Nat Rev Rheumatol. 2011 ; 7: 330-339
4. Giannakopoulos B, Krilis SA. The pathogenesis of the antiphospholipid syndrome. N Engl J Med. 2013 ; 368: 1033-1044
5. Levine J, Subang R, Setty S, et al. Phospholipid-binding proteins differ in their capacity to induce autoantibodies and murine systemic lupus erythematosus. Lupus. 2014 ; 23: 752-768
6. Levine JS, Subang R, Nasr SH, et al. Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus. J Immunol. 2006 ; 177: 6504-6516
7. Munoz LE, van Bavel C, Franz S, Berden J, Herrmann M, van der Vlag J. Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus. 2008 ; 17: 371-375
8. Patel VA, Longacre-Antoni A, Cvetanovic M, et al. The affirmative response of the innate immune system to apoptotic cells. Autoimmunity. 2007 ; 40: 274-280
9. Pieterse E, van der Vlag J. Breaking immunological tolerance in systemic lupus erythematosus. Front Immunol. 2014 ; 5: 164-164
10. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med. 1994 ; 179: 1317-1330
11. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003 ; 349: 1526-1533
12. Salem D, Subang R, Okazaki Y, et al. Multiple MHC class II haplotypes, but limited T cell epitopes per haplotype, are associated with epitope spread to lupus-related autoantibodies [submitted for publication].
13. Tolomeo T, Rico De Souza A, Roter E, et al. T cells demonstrate a Th1-biased response to native β2-glycoprotein I in a murine model of anti-phospholipid antibody induction. Autoimmunity. 2009 ; 42: 292-295